Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Cincinnati, Ohio
- Most recent report
- 8-K, filed Nov 9, 2026
- Incorporated
- Delaware
- Filings on record
- 399 filings
- On EDGAR
- CIK 1782107
- Fiscal year ends
- December
- Filer status
- Emerging growth company
Financials 8 of 19
News 8 of 129
Prospectuses and Registrations 8 of 54
- 424B3 Prospectus supplement for an offering Sep 8, 2026
- S-1/A Registration statement for an offering, amended Aug 31, 2026
- S-1 Registration statement for an offering Aug 12, 2026
- 424B3 Prospectus supplement for an offering Jun 17, 2026
- S-1 Registration statement for an offering Jun 9, 2026
- 424B3 Prospectus supplement for an offering May 12, 2026
- S-1/A Registration statement for an offering, amended May 7, 2026
- POS AM Post-effective amendment to a registration May 7, 2026
Proxies 8 of 17
- DEFA14A Extra proxy material Oct 23, 2026
- DEF 14A Proxy statement for a shareholder vote Oct 7, 2026
- PRE 14A Preliminary proxy statement Sep 17, 2026
- DEFA14A Extra proxy material Sep 14, 2026
- DEF 14A Proxy statement for a shareholder vote Mar 30, 2026
- PRE 14A Preliminary proxy statement Mar 18, 2026
- DEF 14A Proxy statement for a shareholder vote Jan 2, 2026
- PRE 14A Preliminary proxy statement Dec 22, 2025
Ownership 8 of 95
- SCHEDULE 13G/A Large holder reported a passive stake, amended Nov 5, 2026
- SCHEDULE 13G Large holder reported a passive stake Jul 27, 2026
- 4 Insider reported a trade Apr 22, 2026
- 4 Insider reported a trade Apr 21, 2026
- 4 Insider reported a trade Apr 16, 2026
- 3 Insider reported their initial holding Apr 16, 2026
- 3 Insider reported their initial holding Mar 27, 2026
- 3 Insider reported their initial holding Mar 27, 2026
Other 8 of 85
Everything here comes from Onconetix, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.